Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · IEX Real-Time Price · USD
21.98
-0.12 (-0.54%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Rocket Pharmaceuticals Market Cap
Rocket Pharmaceuticals has a market cap or net worth of $1.99 billion as of April 26, 2024. Its market cap has increased by 35.15% in one year.
Market Cap
1.99B
Enterprise Value
1.64B
1-Year Change
35.15%
Ranking
Category
Stock Price
$21.98
Market Cap Chart
Since February 18, 2015, Rocket Pharmaceuticals's market cap has increased from $95.30M to $1.99B, an increase of 1,987.39%. That is a compound annual growth rate of 39.18%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 26, 2024 | 1.99B | -0.54% |
Apr 25, 2024 | 2.00B | -6.48% |
Apr 24, 2024 | 2.14B | -0.17% |
Apr 23, 2024 | 2.14B | -0.84% |
Apr 22, 2024 | 2.16B | 4.69% |
Apr 19, 2024 | 2.06B | -2.89% |
Apr 18, 2024 | 2.13B | -0.84% |
Apr 17, 2024 | 2.14B | -2.35% |
Apr 16, 2024 | 2.19B | 1.00% |
Apr 15, 2024 | 2.17B | -0.74% |
Apr 12, 2024 | 2.19B | -4.31% |
Apr 11, 2024 | 2.29B | 3.52% |
Apr 10, 2024 | 2.21B | -3.67% |
Apr 9, 2024 | 2.29B | 3.94% |
Apr 8, 2024 | 2.21B | -2.48% |
Apr 5, 2024 | 2.26B | 0.12% |
Apr 4, 2024 | 2.26B | -1.77% |
Apr 3, 2024 | 2.30B | -1.05% |
Apr 2, 2024 | 2.33B | -3.82% |
Apr 1, 2024 | 2.42B | -0.82% |
Mar 28, 2024 | 2.44B | -1.14% |
Mar 27, 2024 | 2.47B | 2.60% |
Mar 26, 2024 | 2.40B | -1.27% |
Mar 25, 2024 | 2.43B | -1.14% |
Mar 22, 2024 | 2.46B | -1.81% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Kymera Therapeutics | 2.04B |
CONMED | 2.03B |
Amphastar Pharmaceuticals | 2.01B |
Dyne Therapeutics | 2.01B |
Intellia Therapeutics | 2.00B |
NewAmsterdam Pharma Company | 1.96B |
RxSight | 1.95B |
Avidity Biosciences | 1.94B |